Director, Late-Stage Clinical Strategy & Access

Definium Therapeutics seeks a Director of Late-Stage Clinical Strategy to lead end‑to‑end Expanded Access Programs and late‑stage studies across our portfolio.

You will provide strategic leadership and hands‑on execution in a lean, fast‑moving organization, collaborating with Clinical Development, Regulatory Affairs, HEOR, Medical Affairs, and Commercial teams.

The role is based in the United States with a base pay range and opportunities for bonus and equity.